close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

38.22 -0.89 (-2.28%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Viking Therapeutics, Inc. - Common Stock

< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
28 29 Next >
News headline image
Stocks Are “Coiling” Near All-Time Highs - Mania Could Be Next ↗
If you’ve gotten the sense lately that something is building, you’re not wrong. We’ve seen hyper-concentration in the biggest stocks, to the point where plenty of us are focused on just one. 
Via Talk Markets
News headline image
Dow Dips Over 100 Points; J.M. Smucker Posts Upbeat Earnings ↗
U.S. stocks traded mixed toward the end of trading, with the Dow Jones index falling more than 100 points on Tuesday. The Dow traded down 0.35% to 38,932.26 while the NASDAQ rose 0.28% to 16,021.41.... 
Via Benzinga
Topics Stocks
News headline image
S&P 500, Nasdaq 100 Dip, Small Caps Surge; Bitcoin Tops $57,000, 2 Biotech Stocks Skyrocket: What's Driving Markets Tuesday? ↗
On Tuesday, large-cap indices experienced a downturn, while small caps surged, reflecting investor attention on stock valuations. 
Via Benzinga
Topics Stocks
News headline image
Why Is Ligand Pharmaceuticals Stock Trading Higher Today? ↗
Ligand Pharmaceuticals beats Q4 2023 sales estimates at $28.1 million, with strong core Captisol and royalty figures. CEO Todd Davis highlights transformative 2023 and optimistic guidance for 2024. 
Via Benzinga
News headline image
(VKTX) - Analyzing Viking Therapeutics's Short Interest ↗
 
Via Benzinga
News headline image
Recap: Viking Therapeutics Q4 Earnings ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 7, 2024 ↗
Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per share on revenue of $301.83 million. 
Via Benzinga
News headline image
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Earnings Preview: Viking Therapeutics ↗
 
Via Benzinga
News headline image
Crude Oil Gains 1%; Macy's Plans To Close 150 Stores ↗
U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 150 points on Tuesday. The Dow traded down 0.39% to 38,915.65 while the NASDAQ rose 0.15% to 15,999.50. The S&P... 
Via Benzinga
Topics Stocks
News headline image
3 Biotech Stocks Bound to Blast Off By 2029 ↗
Biotech stocks are risky, but rewarding. These three biotechs specifically could see exponential gains in the coming years. 
Via InvestorPlace
News headline image
Anheuser-Busch Strike: 5 Things to Know as Brewers Gear Up for Walkout ↗
An Anheuser-Busch strike is brewing as the beer company continues troubled negotiations with members of the Teamsters union. 
Via InvestorPlace
News headline image
Norwegian Cruise Line Posts Strong Sales, Joins Hims & Hers Health, Sterling Infrastructure And Other Big Stocks Moving Higher On Tuesday ↗
U.S. stocks were mixed, with the Dow Jones index falling around 100 points on Tuesday. 
Via Benzinga
Topics Stocks
Viking Therapeutics Inc. (NASDAQ: VKTX) Near Top of Volume Charts in Tuesday Trading
Via Investor Brand Network
News headline image
Weight Loss Drug Market Gets Crowded As Viking Therapeutics Drops Encouraging Phase 2 Data From Obesity Study ↗
Viking Therapeutics' VK2735, a dual GLP-1 and GIP receptor agonist, achieved significant weight loss (up to 14.7%) in metabolic disorder patients. Safe, well-tolerated treatment with no observed... 
Via Benzinga
News headline image
Nasdaq Rises 50 Points; Lowe's Earnings Top Views ↗
U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining around 50 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.07% to 39,043.13 while the NASDAQ rose... 
Via Benzinga
Topics Stocks
News headline image
Why Is Viking Therapeutics (VKTX) Stock Up 96% Today? ↗
Viking Therapeutics stock is up on Tuesday with heavy trading of VKTX shares after the company reported positive Phase 2 trial results! 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Viking Therapeutics Skyrockets On Weight-Loss Drug Trial Results ↗
Eli Lilly and Novo Nordisk fell modestly. 
Via Investor's Business Daily
News headline image
Biotech Stocks Madrigal, Altimmune In A Tizzy As New Weight-Loss Rival Enters The Arena ↗
The results from Boehringer Ingelheim and Zealand Pharma bolstered some biotech stocks. But not all got the same boost. 
Via Investor's Business Daily
News headline image
3 Biotech Stocks to Turn $10,000 Into $1 Million: February 2024 ↗
With new innovation and high demand, biotech stocks could offer some of the most explosive opportunities of the year. 
Via InvestorPlace
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
The 3 Biotech Stocks That Could Make Your February Unforgettable ↗
After a blistering hot year of biotech M&A, we’ll see more of the same in 2024. That could be great news for these hot biotech stocks. 
Via InvestorPlace
News headline image
7 Must-Buy Pharma Stocks Amid the Weight Loss Drug Revolution ↗
Obesity drug sales boomed in 2023 and will continue in 2024. That could make these weight loss stocks even more attractive. 
Via InvestorPlace
News headline image
Amazon, Progress Software And 2 Other Stocks Insiders Are Selling ↗
The Nasdaq 100 closed higher by 1% on Friday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
News headline image
The 3 Most Undervalued Biotech Stocks to Buy in February 2024 ↗
With patience, some of the most undervalued biotech stocks can create massive wealth, such as these three to consider. 
Via InvestorPlace
News headline image
Viking Therapeutics Charges To A Record High On An Update For Its Eli Lilly-Rivaling Obesity Drug ↗
The company is looking to take on Eli Lilly's tirzepatide as both a shot and a pill for weight loss. 
Via Investor's Business Daily
News headline image
Arm Holdings Posts Upbeat Results, Joins Hershey, CyberArk Software, Wynn Resorts And Other Big Stocks Moving Higher On Thursday ↗
U.S. stocks traded mixed, with the Dow Jones gaining around 20 points on Thursday. 
Via Benzinga
Topics Stocks
News headline image
Why Compass Minerals International Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Shares of Compass Minerals International, Inc. (NYSE: CMP) fell sharply during Thursday’s session following downbeat results. 
Via Benzinga
< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
28 29 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today